Patients, Supporters Worldwide Recognizing Rare Disease Day 2020
An abundance of events are afoot around the world to mark Rare Disease Day 2020 on Feb. 29. The activities are focused on heightening ... Read more
Updates
-
-
Anti-inflammatory Molecule Safely and Quickly Treats Generalized MG, Phase 2 Trial Reports
An anti-inflammatory molecule, known as the complement inhibitor zilucoplan, was seen to significantly ease disease severity in generalized myasthenia gravis (gMG) patients at its higher ... Read more -
Rare Disease Day in South Africa Is a Chance to Promote Change
Rare Disease Day on Feb. 29 is an important advocacy effort for every one of us fighting a rare disease, every minute of every ... Read more -
Case Report Highlights Very Late-onset MG in Woman, 93
Myasthenia gravis (MG) can occur in very elderly patients, a recent case report highlights. As such, there is a need for early diagnosis in ... Read more -
Rituxan Lessens Disease Severity in Myasthenia Gravis Irrespective of Type of Autoantibodies, Study Reports
Treatment with Rituxan (rituximab) benefits patients with myasthenia gravis (MG) with either anti-acetylcholine receptor (AChR) or muscle-specific tyrosine kinases (MuSKs) antibodies, a study has found. Patients ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
Patients, Supporters Worldwide Recognizing Rare Disease Day 2020
An abundance of events are afoot around the world to mark Rare Disease Day ... -
Anti-inflammatory Molecule Safely and Quickly Treats Generalized MG, Phase 2 Trial Reports
An anti-inflammatory molecule, known as the complement inhibitor zilucoplan, was seen to significantly ease ... -
Rare Disease Day in South Africa Is a Chance to Promote Change
Rare Disease Day on Feb. 29 is an important advocacy effort for every one ... -
Case Report Highlights Very Late-onset MG in Woman, 93
Myasthenia gravis (MG) can occur in very elderly patients, a recent case report highlights. ... -
Rituxan Lessens Disease Severity in Myasthenia Gravis Irrespective of Type of Autoantibodies, Study Reports
Treatment with Rituxan (rituximab) benefits patients with myasthenia gravis (MG) with either anti-acetylcholine receptor (AChR) or ... -
My Body and Mind Are Exhausted Following Chemotherapy
I had chemotherapy about 10 days ago and returned to work later that day ...
Women with Myasthenia Gravis Report Lower Quality of Life than Male MG Patients, Study Finds
News
Women with myasthenia gravis (MG) have a poorer quality of life than male patients. That’s the conclusion of a study named “Best Abstract Award” winner at the 2017 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Phoenix. Specifically, ... Read more